A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery among US adolescents increased from 2021 to 2023.

Some of the nation's top brain researchers are facing layoffs, even after HHS Secretary RFK Jr said no working scientists would be cut.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.